| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1983) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| ATC: | B05XA08 |
| UNII: | 4550K0SC9B |
Structure
| InChI Key | VMHLLURERBWHNL-UHFFFAOYSA-M |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C2H3NaO2 |
| Molecular Weight | 82.03 |
| AlogP | None |
| Hydrogen Bond Acceptor | None |
| Hydrogen Bond Donor | None |
| Number of Rotational Bond | None |
| Polar Surface Area | None |
| Molecular species | None |
| Aromatic Rings | None |
| Heavy Atoms | None |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Lyase
|
- | - | - | 130000-130000 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Lipid-like ligand receptor (family A GPCR)
Free fatty acid receptor
|
1000000 | - | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ornithine Carbamoyltransferase Deficiency Disease | 3 | D020163 | ClinicalTrials |
| Brain Neoplasms | 2 | D001932 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
Related Entries
Adverse Reactions
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 127-09-3 |
| ChEBI | 32954 |
| ChEMBL | CHEMBL1354 |
| DrugBank | DB09395 |
| EPA CompTox | DTXSID2027044 |
| FDA SRS | 4550K0SC9B |
| PubChem | 517045 |
| SureChEMBL | SCHEMBL2289 |
CONTENTS